Precision Biosciences (DTIL) Invested Capital (2021 - 2024)

Precision Biosciences (DTIL) has reported Invested Capital for 3 consecutive years, with $22.5 million the latest figure, recorded in Q2 2024.

• In Q2 2024, Invested Capital rose 0.79% year-over-year to $22.5 million; the TTM figure through Mar 2025 stood at $22.5 million (down 74.88% YoY), while the FY2023 annual figure was $22.4 million, changed N/A from the prior year.
• Invested Capital steadied at $22.5 million in Q2 2024 per DTIL's latest filing, from $22.5 million in the prior quarter.
• Across five years, Invested Capital topped out at $22.5 million in Q2 2024 and bottomed at $2.4 million in Q2 2021.
• Historically, Invested Capital has averaged $16.7 million across 3 years, with a median of $22.4 million in 2023.
• On a YoY basis, Invested Capital climbed as much as 0.79% in 2024 and fell as far as 0.79% in 2024.
• Precision Biosciences' Invested Capital stood at $2.5 million in 2021, then surged by 813.28% to $22.4 million in 2023, then advanced by 0.37% to $22.5 million in 2024.
• Business Quant data shows DTIL's Invested Capital at $22.5 million in Q2 2024, $22.5 million in Q1 2024, and $22.4 million in Q4 2023.